PAX5 and breast cancer: Accordingly, a study by Ellsworth et al. (2009) demonstrates that relative PAX5 expression levels are 100-fold greater in metastasized breast cancer cells located in patient lymph nodes in comparison to levels found in their primary tumor counterparts [122].